70 related articles for article (PubMed ID: 9376074)
1. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.
Wagner DH; Vaitaitis G; Sanderson R; Poulin M; Dobbs C; Haskins K
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3782-7. PubMed ID: 11891296
[TBL] [Abstract][Full Text] [Related]
2. A Hypermorphic
Presa M; Racine JJ; Dwyer JR; Lamont DJ; Ratiu JJ; Sarsani VK; Chen YG; Geurts A; Schmitz I; Stearns T; Allocco J; Chapman HD; Serreze DV
J Immunol; 2018 Oct; 201(7):1907-1917. PubMed ID: 30127089
[TBL] [Abstract][Full Text] [Related]
3. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
Feuerer M; Jiang W; Holler PD; Satpathy A; Campbell C; Bogue M; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18181-6. PubMed ID: 17991775
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice.
Recino A; Gan SU; Sia KC; Sawyer Y; Trendell J; Kay R; Gribble FM; Reimann F; Foale R; Notaridou M; Holmes N; Lever A; Lee KO; Nathwani A; Cooke A; Calne R; Wallberg M
Gene Ther; 2019 Feb; 26(1-2):40-56. PubMed ID: 30514969
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes.
Wang X; Hao J; Metzger DL; Mui A; Ao Z; Akhoundsadegh N; Langermann S; Liu L; Chen L; Ou D; Verchere CB; Warnock GL
Diabetes; 2011 Dec; 60(12):3246-55. PubMed ID: 21984581
[TBL] [Abstract][Full Text] [Related]
6. Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice: Possible Relationship With the Pathogenesis of Type 1 Autoimmune Diabetes.
Mendes-da-Cruz DA; Lemos JP; Passos GA; Savino W
Front Endocrinol (Lausanne); 2018; 9():381. PubMed ID: 30050502
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune diabetes: ongoing development of immunological intervention strategies targeted directly against autoreactive T cells.
Sia C
Rev Diabet Stud; 2004; 1(1):9-17. PubMed ID: 17491660
[TBL] [Abstract][Full Text] [Related]
8. Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.
Coulaud J; Durant S; Homo-Delarche F
Rev Diabet Stud; 2010; 7(1):36-46. PubMed ID: 20703437
[TBL] [Abstract][Full Text] [Related]
9. Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.
Throsby M; Coulaud J; Durant S; Homo-Delarche F
Rev Diabet Stud; 2005; 2(2):75-83. PubMed ID: 17491682
[TBL] [Abstract][Full Text] [Related]
10. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
11. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
12. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of T cell receptor ligation of TCR gamma delta thymocyte development in fetal thymic organ culture.
Tatsumi Y; Deluca D; Cron RQ; Bluestone JA
Thymus; 1994-1995; 23(3-4):131-53. PubMed ID: 8525502
[TBL] [Abstract][Full Text] [Related]
14. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
15. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
